---
title: "Curatis and Neupharma sign development agreement for corticorelin in Japan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/278862080.md"
description: "A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser."
datetime: "2026-03-12T10:13:44.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/278862080.md)
  - [en](https://longbridge.com/en/news/278862080.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/278862080.md)
---

# Curatis and Neupharma sign development agreement for corticorelin in Japan

A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.

### Related Stocks

- [3671.JP](https://longbridge.com/en/quote/3671.JP.md)
- [4528.JP](https://longbridge.com/en/quote/4528.JP.md)

## Related News & Research

- [MSD, Daiichi Sankyo’s ifinatamab deruxtecan receives FDA priority](https://longbridge.com/en/news/282660056.md)
- [J&J sets the tone for Q1 earnings with strong oncology growth](https://longbridge.com/en/news/282867051.md)
- [FDA shares guide on genome editing best practices](https://longbridge.com/en/news/282873358.md)
- [Shionogi secures $482m BARDA contract to tackle AMR crisis](https://longbridge.com/en/news/282168457.md)
- [CGT’s next obstacle: Securing the leukapheresis supply chain](https://longbridge.com/en/news/281853614.md)